Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer
W. A. Hall, A. V. Petrova, L. E. Colbert, C. W. Hardy, S. B. Fisher, B. Saka, J. W. Shelton, M. D. Warren, B. G. Pantazides, K. Gandhi, J. Kowalski, D. A. Kooby, B. F. El-Rayes, C. A. Staley, N. Volkan Adsay, W. J. Curran, J. C. Landry, S. K. Maithel, D. S. Yu*
Dive into the research topics of 'Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer'. Together they form a unique fingerprint.